Aequus Provides Update and Reports Third Quarter 2024 Financial Highlights
VANCOUVER – TheNewswire – November 8, 2024 – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing, and promoting...
Read More